HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Westergaard Selected Research

NSC 314622

3/2001Inhibition of Flp recombinase by the topoisomerase I-targeting drugs, camptothecin and NSC-314622.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Westergaard Research Topics

Disease

2Neoplasms (Cancer)
03/2001 - 04/2000
1Werner Syndrome (Werner's Syndrome)
09/2000

Drug/Important Bio-Agent (IBA)

1NSC 314622IBA
03/2001
1CamptothecinIBA
03/2001
1Type I DNA Topoisomerases (Topoisomerase I)IBA
03/2001
1Recombinases (Recombinase)IBA
03/2001
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
03/2001
1Proteins (Proteins, Gene)FDA Link
09/2000
1A-Form DNA (A-DNA)IBA
09/2000
1EnzymesIBA
04/2000